CNNE vs GSK · rev $198.4M vs P/E 13, $103.31B cap
Cannae Holdings Inc (CNNE) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
Cannae Holdings Inc (CNNE) is a restaurants company listed on NYSE.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported CNNE revenue for 2026-06-30 was $198.4M. Net income was $5.4M. CNNE currently screens at market cap $622.4M.
GSK does not have a complete income-statement cache yet.
CNNE currently screens at market cap $622.4M. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the CNNE and GSK stock pages for the full models.
Not investment advice.